These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3643996)
21. Use of natural surfactants to prevent and treat respiratory distress syndrome. Spafford PS; Kendig JW; Maniscalco WM Semin Perinatol; 1993 Aug; 17(4):285-94. PubMed ID: 8140443 [No Abstract] [Full Text] [Related]
22. Surfactant treatment for premature babies--a review of clinical trials. Morley CJ Arch Dis Child; 1991 Apr; 66(4 Spec No):445-50. PubMed ID: 2025043 [No Abstract] [Full Text] [Related]
23. Neonatal respiratory distress syndrome and surfactant therapy; a brief review. Robertson B Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999 [TBL] [Abstract][Full Text] [Related]
24. Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome. Merritt TA; Hallman M; Spragg R; Heldt GP; Gilliard N Drugs; 1989 Oct; 38(4):591-611. PubMed ID: 2684594 [TBL] [Abstract][Full Text] [Related]
26. Exogenous surfactant in neonatal respiratory distress syndrome. Cashore WJ R I Med; 1995 Jan; 78(1):7-10. PubMed ID: 7873814 [No Abstract] [Full Text] [Related]
27. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Soll RF; Morley CJ Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966 [TBL] [Abstract][Full Text] [Related]
29. On exogenous surfactant therapy. Gortner L Pediatr Pulmonol; 1993 Feb; 15(2):128-9. PubMed ID: 8474786 [No Abstract] [Full Text] [Related]
30. Effects of surfactant therapy on outcome of infants with birth weights of 600 to 750 grams. Ferrara TB; Hoekstra RE; Couser RJ; Jackson JC; Anderson CL; Myers TF; Raye JR J Pediatr; 1991 Sep; 119(3):455-7. PubMed ID: 1880661 [No Abstract] [Full Text] [Related]
31. Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf). Wach R; Darlow B; Bourchier D; Broadbent R; Knight D; Selby R N Z Med J; 1994 Jun; 107(980):234-7. PubMed ID: 8208494 [TBL] [Abstract][Full Text] [Related]
36. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Soll R; Ozek E Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177 [TBL] [Abstract][Full Text] [Related]
37. Surfactant replacement therapy: issues related to currently available preparations. Bose G Neonatal Netw; 1992 Jun; 11(4):vii-xii. PubMed ID: 1608367 [No Abstract] [Full Text] [Related]
38. Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond. Sürmeli-Onay O; Korkmaz A; Yiğit S; Yurdakök M Turk J Pediatr; 2012; 54(3):239-46. PubMed ID: 23094533 [TBL] [Abstract][Full Text] [Related]
39. [Treatment of surfactant deficiency conditions in neonates with exogenous surfactant]. Javorka K; Calkovská A Cesk Pediatr; 1993 Jul; 48(7):443-7. PubMed ID: 8374987 [No Abstract] [Full Text] [Related]
40. [Surfactant substitution in respiratory distress syndrome. Nursing necessities for the care of a premature with respiratory distress syndrome after surfactant substitution]. Napierala S Kinderkrankenschwester; 1992 Jul; 11(7):253-4. PubMed ID: 1498030 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]